Skip to content

Tag: Retinitis Pigmentosa

Development of Visual Function Evaluation Method

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Development of Visual Function Evaluation Method Condition:   Retinitis PigmentosaIntervention:   Sponsor:   Astellas Pharma IncNot yet recruiting – verified September 2017 Source: ClinicalTrials.gov – Retinitis Pigmentosa – Development of Visual Function Evaluation Method

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Retinal prosthesis could enable blind to see shapes, even text

Source: Google News – Retinitis pigmentosa – Retinal prosthesis could enable blind to see shapes, even text Retinal prosthesis could enable blind to see shapes, even text  The San Diego Union-Tribune Full coverage Source: Google News – Retinitis pigmentosa – Retinal prosthesis could enable blind to see shapes, even…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Second Sight Medical Products Inc. – Receive News & Ratings Daily

Source: Google News – Retinitis pigmentosa – Second Sight Medical Products Inc. – Receive News & Ratings Daily Second Sight Medical Products Inc. – Receive News & Ratings Daily  TrueBlueTribune Full coverage Source: Google News – Retinitis pigmentosa – Second Sight Medical Products Inc. – Receive News & Ratings…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Analysts Set Applied Genetic Technologies Corporation (AGTC) Price Target at $14.63

Source: Google News – Retinitis pigmentosa – Analysts Set Applied Genetic Technologies Corporation (AGTC) Price Target at .63 Analysts Set Applied Genetic Technologies Corporation (AGTC) Price Target at $14.63  TrueBlueTribune EPS for Applied Genetic Technologies Corp (AGTC) Expected At $0.11  WeeklyHub Full coverage Source: Google News – Retinitis pigmentosa –…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Second Sight Medical Products Inc. – Receive News & Ratings Daily

Source: Google News – Retinitis pigmentosa – Second Sight Medical Products Inc. – Receive News & Ratings Daily Second Sight Medical Products Inc. – Receive News & Ratings Daily  The Cerbat Gem Second Sight Medical Products’ (NASDAQ:EYES) Buy Rating Reaffirmed at HC Wainwright  Sports Perspectives Full coverage Source: Google News…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest